Sanacure SRL
7.6 FTESanacure reported total assets of 595,496 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Aug 2026), with 7.6 full-time equivalents.
The score of Sanacure shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -72 % Total assets -8 % Headcount (avg FTE) +77 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sanacure's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Aug 2026
- Year ended 31 Dec 2024filed on 30 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 29 Aug 2022
Sanacure's financial analysis
- Solvency10.4%sector median: 43.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sanacure
Sanacure's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0701.968.115
- VAT number
- BE0701968115
- Peppol
- Registered · 0208:0701968115 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 31 Aug 2018
- Registered office
- 5363 Hamois
- Size
- Micro · 7.6 FTE
- Latest accounts
- 2025 · filed on 28 Aug 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Sanacure (SRL) has been based in Hamois since 2018, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 278 € and equity of 62,056 €; its revenue is not published. With 7.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 10.4%, below the median of its sector (43.9%).
Companies similar to Sanacure
Companies in the same business, of comparable size and area, outside its group.
- Endoceutics Wholesale of pharmaceutical and medical goods Brussels · balance sheet €3.45m
- Launchpad Europe Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet 120,635 €
- Maimonides Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 142 €
- Biocon Biologics Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €1.09m
- Wimeq Wholesale of pharmaceutical and medical goods Heusden-Zolder · balance sheet 48,978 €
- MiniMed Belgium Wholesale of pharmaceutical and medical goods Brussels · balance sheet 8,076 €
- NEW Instruphar Wholesale of pharmaceutical and medical goods Ghent · balance sheet 599,845 €
- Immo Vita Wholesale of pharmaceutical and medical goods Braine-l'Alleud · balance sheet 609,667 €
Frequently asked questions about Sanacure
What is the revenue of Sanacure?
Sanacure files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Sanacure?
In Belgium, the VAT number is the company number prefixed with BE: BE0701968115 for Sanacure, if the company is VAT-registered. Its company number (CBE) is 0701.968.115.
Where is the registered office of Sanacure?
According to the CBE register, the registered office of Sanacure is in 5363 Hamois.
What is the equity of Sanacure?
At the close of the 2025 financial year, the equity of Sanacure amounts to 62,056 €, a solvency of 10.4% of total assets.
How many people work at Sanacure?
7.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Sanacure?
The register lists 3 active mandates at Sanacure. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sanacure
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →